Nneoma S Wamkpah1, Andrew M Peterson2, Jake J Lee1, Lena Jia3, Angela Hardi4, Carolyn Stoll5, Molly Huston6. 1. Department of Otolaryngology-Head and Neck Surgery, Washington University in St. Louis, St. Louis, Missouri, U.S.A. 2. University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, U.S.A. 3. Washington University School of Medicine, St. Louis, Missouri, U.S.A. 4. Bernard Becker Medical Library, Washington University in St. Louis, St. Louis, Missouri, U.S.A. 5. Washington University Division of Public Health Sciences, St. Louis, Missouri, U.S.A. 6. Division of Laryngology, Department of Otolaryngology-Head and Neck Surgery, Washington University in St Louis, St. Louis, Missouri, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: Neurogenic cough affects 11% of Americans and causes significant detriment to quality of life. With the advent of novel therapies, the objective of this review is to determine how procedural therapies (e.g., superior laryngeal nerve block) compare to other established pharmacologic and non-pharmacologic treatments for neurogenic cough. METHODS: With the assistance of a medical librarian, a systematic review was performed using PICOS (patients, interventions, comparator, outcome, study design) format: adults with neurogenic cough receiving any pharmacologic or non-pharmacologic treatment for neurogenic cough compared to adults with neurogenic cough receiving any other relevant interventions, or treated as single cohorts, assessed with cough-specific quality of life outcomes, in all study designs and case series with ≥ 10 cases. Case reports, review articles, non-human studies, non-English language articles, and unavailable full-text articles were excluded. RESULTS: There were 2408 patients with neurogenic cough in this review, treated with medical therapy (77%), speech therapy (19%), both medical and speech therapy (1%), and procedural therapy (3%). The included studies ranged from low to intermediate quality. Overall, most interventions demonstrated successful improvement in cough. However, the heterogeneity of included study designs precluded direct comparisons between intervention types. CONCLUSION: This meta-analysis compared various treatments for neurogenic cough. Procedural therapy should be considered in the armamentarium of neurogenic cough treatments, particularly in patients refractory to, or intolerant of, the side effects of medical therapy. Lastly, this review illuminates key areas for improving neurogenic cough diagnosis, such as strict adherence to diagnostic and treatment guidelines, sophisticated reflux testing, and standardized, consistent outcome reporting. Laryngoscope, 132:107-123, 2022.
OBJECTIVES/HYPOTHESIS: Neurogenic cough affects 11% of Americans and causes significant detriment to quality of life. With the advent of novel therapies, the objective of this review is to determine how procedural therapies (e.g., superior laryngeal nerve block) compare to other established pharmacologic and non-pharmacologic treatments for neurogenic cough. METHODS: With the assistance of a medical librarian, a systematic review was performed using PICOS (patients, interventions, comparator, outcome, study design) format: adults with neurogenic cough receiving any pharmacologic or non-pharmacologic treatment for neurogenic cough compared to adults with neurogenic cough receiving any other relevant interventions, or treated as single cohorts, assessed with cough-specific quality of life outcomes, in all study designs and case series with ≥ 10 cases. Case reports, review articles, non-human studies, non-English language articles, and unavailable full-text articles were excluded. RESULTS: There were 2408 patients with neurogenic cough in this review, treated with medical therapy (77%), speech therapy (19%), both medical and speech therapy (1%), and procedural therapy (3%). The included studies ranged from low to intermediate quality. Overall, most interventions demonstrated successful improvement in cough. However, the heterogeneity of included study designs precluded direct comparisons between intervention types. CONCLUSION: This meta-analysis compared various treatments for neurogenic cough. Procedural therapy should be considered in the armamentarium of neurogenic cough treatments, particularly in patients refractory to, or intolerant of, the side effects of medical therapy. Lastly, this review illuminates key areas for improving neurogenic cough diagnosis, such as strict adherence to diagnostic and treatment guidelines, sophisticated reflux testing, and standardized, consistent outcome reporting. Laryngoscope, 132:107-123, 2022.
Authors: Surinder S Birring; Marlies S Wijsenbeek; Sanjay Agrawal; Jan W K van den Berg; Helen Stone; Toby M Maher; Ahmet Tutuncu; Alyn H Morice Journal: Lancet Respir Med Date: 2017-09-08 Impact factor: 30.700
Authors: Gregory R Dion; Stephanie E Teng; Efstratios Achlatis; Yixin Fang; Milan R Amin Journal: Otolaryngol Head Neck Surg Date: 2017-05-02 Impact factor: 3.497
Authors: M M Pizzichini; E Pizzichini; K Parameswaran; L Clelland; A Efthimiadis; J Dolovich; F E Hargreave Journal: Can Respir J Date: 1999 Jul-Aug Impact factor: 2.409
Authors: Ana Maria Ilicic; Ana Oliveira; Razanne Habash; Yejin Kang; Michelle Kho; Roger Goldstein; Dina Brooks Journal: Front Rehabil Sci Date: 2022-05-26